At present, much literature has discussed the clinical role of VASH1 in gastric cancer [9], ovarian cancer [10], colorectal cancer [11], esophageal cancer [12], prostate cancer [13], and nonsmall cell lung cancer [14]. This evidence concerns the gene VASH1 and esophageal cancer.